<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="epub">2692-8205</issn></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS199188</article-id><article-id pub-id-type="doi">10.1101/2024.10.01.616071</article-id><article-id pub-id-type="archive">PPR918978</article-id><article-version-alternatives><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">1</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Structure and stabilization of the antigenic glycoprotein building blocks of the New World mammarenavirus spike complex</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Paesen</surname><given-names>Guido C.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="corresp" rid="CR1">#</xref></contrib><contrib contrib-type="author"><name><surname>Ng</surname><given-names>Weng M.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Sutton</surname><given-names>Geoff</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Doores</surname><given-names>Katie J.</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Bowden</surname><given-names>Thomas A.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="corresp" rid="CR1">#</xref></contrib></contrib-group><aff id="A1"><label>1</label>Division of Structural Biology, Centre for Human Genetics, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/052gg0110</institution-id><institution>University of Oxford</institution></institution-wrap>, <city>Oxford</city>, <postal-code>OX3 7BN</postal-code>, <country country="GB">UK</country></aff><aff id="A2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00gqx0331</institution-id><institution>Research Complex at Harwell</institution></institution-wrap>, Harwell Science and Innovation Centre, <city>Didcot</city>, <postal-code>OX11 0FA</postal-code>, <country country="GB">UK</country></aff><aff id="A3"><label>3</label>Electron Bio-Imaging Centre, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/05etxs293</institution-id><institution>Diamond Light Source</institution></institution-wrap>, <city>Didcot</city>, <postal-code>OX11 0DE</postal-code>, <country country="GB">UK</country></aff><aff id="A4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0220mzb33</institution-id><institution>Kings College London</institution></institution-wrap>, Department of Infectious Diseases, <addr-line>2nd Floor, Borough Wing</addr-line>, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/04r33pf22</institution-id><institution>Guy’s Hospital</institution></institution-wrap>, <addr-line>Great Maze Pond</addr-line>, <city>London</city>, <postal-code>SE1 9RT</postal-code>, <country country="GB">UK</country></aff><author-notes><corresp id="CR1">
<label>#</label><italic>To whom correspondence should be addressed Corresponding authors: Guido Paesen</italic>, <email>guido.paesen@strubi.ox.ac.uk</email> <italic>Thomas A. Bowden</italic>, <email>thomas.bowden@strubi.ox.ac.uk</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>04</day><month>10</month><year>2024</year></pub-date><pub-date pub-type="preprint"><day>01</day><month>10</month><year>2024</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0 International license</ext-link>.</license-p></license></permissions><abstract><p id="P1">The spillover of New World (NW) arenaviruses from rodent reservoirs into human populations poses a continued risk to human health. NW arenaviruses present a glycoprotein (GP) complex on the envelope surface of the virion, which orchestrates host-cell entry and is a key target of the immune response arising from infection and immunization. Each protomer of the trimeric GP is composed of a stable signal peptide (SSP), a GP1 attachment glycoprotein, and a GP2 fusion glycoprotein. To glean insights into the architecture of this key therapeutic target, we determined the crystal structures of NW GP1-GP2 heterodimeric complexes from Junín virus (JUNV) and Machupo virus (MACV). Due to the metastability of the interaction between GP1 and GP2, structural elucidation required the introduction of a disulfide bond at the GP1-GP2 complex interface, but no other stabilizing modifications were required. While the overall assembly of NW GP1-GP2 is conserved with that presented by Old World (OW) arenaviruses, including Lassa virus (LASV) and lymphocytic choriomeningitis virus (LCMV), NW GP1-GP2 complexes are structurally distinct. Indeed, we note that when compared to the OW GP1-GP2 complex, the globular portion of NW GP1 undergoes limited structural alterations upon detachment from its cognate GP2. We further demonstrate that our engineered GP1-GP2 heterodimers are antigenically relevant and recognized by neutralizing antibodies. These data provide insights into the distinct assemblies presented by NW and OW arenaviruses, as well as provide molecular-level blueprints that may guide vaccine development.</p></abstract><kwd-group><kwd>arenavirus</kwd><kwd>glycoprotein</kwd><kwd>structure</kwd><kwd>rational immunogen design</kwd><kwd>virus-host interactions</kwd></kwd-group></article-meta></front><body><sec id="S1" sec-type="intro"><title>Introduction</title><p id="P2">Arenaviruses (family <italic>Arenaviridae</italic>, order <italic>Bunyavirales</italic>) comprise a group of genetically diverse, single-stranded, ambi-sense RNA viruses. Several mammalian-borne arenaviruses (genus <italic>Mammarenavirus</italic>) have repeatedly demonstrated the ability to spill over from rodent hosts and cause hemorrhagic fever or neurological disease in humans (<xref ref-type="bibr" rid="R1">1</xref>, <xref ref-type="bibr" rid="R2">2</xref>). Mammarenaviruses are split into OW and NW lineages, and the NW lineage is further divided into four clades (A-D). The OW lineage includes the highly pathogenic Lassa virus (LASV), found in West Africa (<xref ref-type="bibr" rid="R3">3</xref>), and LCMV, which is prevalent across the globe (<xref ref-type="bibr" rid="R4">4</xref>). NW arenaviruses are endemic to the Americas and include the causative agents of Argentinian (Junín virus, JUNV) and Bolivian hemorrhagic fever (Machupo virus, MACV), both of which are clade B viruses (<xref ref-type="bibr" rid="R5">5</xref>). Apart from the live-attenuated Candid#1 strain of JUNV, which is licensed for use only in Argentina, no vaccines are available for human use against NW arenaviruses (<xref ref-type="bibr" rid="R6">6</xref>).</p><p id="P3">The arenavirus envelope surface is decorated with trimeric glycoprotein (GP) spikes, which are responsible for negotiating host-cell recognition and entry (<xref ref-type="bibr" rid="R7">7</xref>–<xref ref-type="bibr" rid="R10">10</xref>). Each protomer of the GP trimer consists of three non-covalently linked subcomponents (<xref ref-type="bibr" rid="R11">11</xref>): a stable signal peptide (SSP), a membrane-distal GP1 attachment glycoprotein, and a membrane-anchored GP2 glycoprotein, which are the result of proteolytic processing of a single SSP-GP1-GP2 chain in the endoplasmic reticulum. Signal Peptidase (SPase) cleaves the chain between the long, conserved SSP and the nascent GP1-GP2 segment, which is then processed by subtilisin kexin isoenzyme 1 (SKI-1) (<xref ref-type="bibr" rid="R12">12</xref>). In LASV, SKI-1 cleavage promotes spike assembly by increasing inter-protomer complementarity at the trimer interface (<xref ref-type="bibr" rid="R13">13</xref>). Moreover, the liberated, SKI-I site containing loop at the C-terminus of each GP1 (herein referred to as SKI-loop) helps to stabilize the trimer by forming bonds with a neighboring GP1-GP2 heterodimer, whilst apically exposed SKI-site residues are involved in receptor binding (<xref ref-type="bibr" rid="R14">14</xref>).</p><p id="P4">To facilitate endocytosis, GP1 interacts with host-cell receptors, including transferrin receptor 1 (TfR1; used by clade B and D NW viruses), α-dystroglycan (LASV, LCMV, clade C NW viruses) and neuropilin-2 (Lujo virus; LUJV) (<xref ref-type="bibr" rid="R15">15</xref>–<xref ref-type="bibr" rid="R21">21</xref>). Reflective of the diversity of receptors and permissive host species, GP1 exhibits considerable sequence variation, in contrast to the more conserved GP2 (<xref ref-type="bibr" rid="R22">22</xref>). Furthermore, OW LASV uses the endosomal receptor, Lysosome-Associated Membrane Protein 1 (LAMP1), which helps to facilitate membrane fusion (<xref ref-type="bibr" rid="R23">23</xref>), whilst OW LCMV targets the mucin region of CD164 (<xref ref-type="bibr" rid="R24">24</xref>). To date, no such intracellular receptors have been identified to be utilized by NW viruses during host-cell entry.</p><p id="P5">Following host-cell attachment and internalization, GP1 is expected to detach from the spike in acidic endosomes, enabling GP2 to enact its role as a class-I-fusion protein (<xref ref-type="bibr" rid="R10">10</xref>). GP2-mediated fusion occurs through insertion of bipartite fusion domains (<xref ref-type="bibr" rid="R25">25</xref>) into the endosomal membrane. Merging of the viral and endosomal membranes creates a fusion pore, allowing release of viral ribonucleoprotein complexes into the cytoplasm, where viral gene transcription and genome replication take place (<xref ref-type="bibr" rid="R5">5</xref>, <xref ref-type="bibr" rid="R26">26</xref>).</p><p id="P6">A wide range of structural information is available for the OW virus GP. Both GP1/GP2 subcomponents and higher-order OW GP complexes have been resolved, alone and in complex with receptors and with Fab fragments of neutralizing antibodies (<xref ref-type="bibr" rid="R13">13</xref>, <xref ref-type="bibr" rid="R14">14</xref>, <xref ref-type="bibr" rid="R27">27</xref>–<xref ref-type="bibr" rid="R36">36</xref>). In contrast, structural information about NW GPs is limited to isolated GP1 and post-fusion GP2 subcomponents, either alone (<xref ref-type="bibr" rid="R32">32</xref>, <xref ref-type="bibr" rid="R37">37</xref>, <xref ref-type="bibr" rid="R38">38</xref>) or in complex with Fabs (<xref ref-type="bibr" rid="R39">39</xref>–<xref ref-type="bibr" rid="R42">42</xref>) or with human TfR1 (<xref ref-type="bibr" rid="R43">43</xref>). The absence of molecular-level insights into the higher-order NW GP complex may be attributed, in part, to the metastable nature of GP2 and its non-covalent association with GP1.</p><p id="P7">Although the NW GP complex is the primary target of the neutralizing antibody response arising from infection (<xref ref-type="bibr" rid="R10">10</xref>), little is known about how GP1 and GP2, the antigenic building blocks of this key vaccine target, interact. Here, we address this paucity of information through X-ray crystallographic determination of JUNV and MACV GP1-GP2 heterodimers in complex with the Fab fragments of neutralizing antibodies. Structural elucidation required the introduction of a disulfide bridge between GP1 and GP2, which stabilized and allowed production of the protein. Our data provide blueprints that will assist ongoing vaccine development efforts against NW arenaviruses.</p></sec><sec id="S2" sec-type="results"><title>Results</title><sec id="S3"><title>Expression and purification of NW GP1-GP2 heterodimers</title><p id="P8">Given the importance of NW GPs as vaccine targets, we sought to characterize the structural basis for how the interaction between GP1 and GP2 stabilizes this metastable complex. Focusing on GP from NW JUNV, we created a construct with an inter-subunit GP1-GP2 disulfide bond, further incorporating modifications utilized for the production of LASV GP1-GP2<sup>e</sup> complexes (where ‘<sup>e</sup>’ denotes ectodomain) as a guide (<xref ref-type="bibr" rid="R13">13</xref>) (<xref ref-type="fig" rid="F1">Fig.1</xref>, <bold>Supplementary Fig. S1</bold>). These modifications included replacement of the SKI-1 cleavage site with a furin cleavage site for improved processing efficiency, and the introduction of a proline substitution to prevent helices from forming or extending, as also utilized in SARS-CoV-2 spike (<xref ref-type="bibr" rid="R44">44</xref>). Recombinant protein production was performed in insect (<italic>Spodoptera</italic>) cells. Yields of purified protein for constructs with cysteines introduced at positions 88 and 329 (termed JUNV GP1<sup>88-329</sup>GP2<sup>e</sup>), and 88 and 328 (JUNV GP1<sup>88-328</sup>GP2<sup>e</sup>) resulted in the highest yields of purified protein (<bold>Supplementary Figs. S1B</bold> and <bold>S1C</bold>). Additionally, SDS-PAGE and size exclusion chromatography analysis revealed successful inter-chain disulfide-bond incorporation, furin cleavage, and the formation of the expected heterodimeric species (<bold>Supplementary Fig. S2</bold>). Introduction of inter-chain disulfide bonds at equivalent positions in other NW-virus GP1-GP2 constructs, including MACV (at positions 88 and 340, MACV GP1<sup>88-340</sup>GP2<sup>e</sup>), were similarly successful (<bold>Supplementary Figs. S2</bold> and <bold>S3</bold>). Further, production of OW LASV GP1-GP2 and LUJV GP1-GP2 complexes with analogous construct modifications also resulted in successful production of processed recombinant protein, albeit to relatively lower levels of expression (<bold>Supplementary Fig. S3</bold>).</p></sec><sec id="S4"><title>Structures of JUNV GP1<sup>88-329</sup>GP2<sup>e</sup> and MACV GP1<sup>88-340</sup>GP2<sup>e</sup></title><p id="P9">Furin-cleaved JUNV GP1<sup>88-329</sup>GP2<sup>e</sup> and MACV GP1<sup>88-340</sup>GP2<sup>e</sup> formed complexes with the Fab fragments of GP1-targeting neutralizing mAbs, JUN1 and MAC1, respectively (<xref ref-type="bibr" rid="R39">39</xref>), confirming the integrity of their folds. The complexes were crystallized and structurally elucidated to resolutions of 2.1 Å (JUNV-Fab JUN1) and 2.4 Å (MACV-Fab MAC1) (<xref ref-type="fig" rid="F1">Fig. 1</xref>, <bold>Supplementary Table 1</bold>). As expected, the JUNV and MACV GP1-GP2<sup>e</sup> structures are similar (<xref ref-type="fig" rid="F1">Fig. 1</xref>, root-mean-square deviation (RMSD) of 1.9 Å), with differences localized predominantly to the 11 residue insertion in MACV GP1 (<bold>Supplementary Fig. S4</bold>), as described in previous structural studies (<xref ref-type="bibr" rid="R40">40</xref>, <xref ref-type="bibr" rid="R45">45</xref>). JUNV and MACV GP1-GP2 are recognized by Fabs JUN1 and MAC1, respectively, at previously characterized epitopes located at their TfR1 recognition sites (<xref ref-type="bibr" rid="R39">39</xref>).</p><p id="P10">JUNV GP1 and MACV GP1 sit above the predominantly α-helical GP2s (<xref ref-type="fig" rid="F1">Fig. 1C and F</xref>). Similar to their isolated structures, JUNV and MACV GP1 glycoproteins in GP2-bound forms consist of seven-stranded β-sheets (β3-9) interspersed with helical regions (<bold>Supplementary Fig. S4</bold>) (<xref ref-type="bibr" rid="R39">39</xref>, <xref ref-type="bibr" rid="R41">41</xref>, <xref ref-type="bibr" rid="R43">43</xref>). Overlay of GP2-bound JUNV and MACV GP1 onto their GP2 free states (PDB ID 7QU2 and 7QU1, respectively) resulted in low RMSDs (1.1 Å and 0.8 Å, respectively). This structural similarity is also reflected in structure-based classification analysis (<xref ref-type="fig" rid="F2">Fig. 2</xref>), and indicates that unlike OW LASV GP1 (<xref ref-type="bibr" rid="R32">32</xref>, <xref ref-type="bibr" rid="R46">46</xref>), the globular portion of NW GP1 shows only limited structural differences between the GP2-free and GP2-bound states (<bold>Supplementary Fig. S5</bold>).</p><p id="P11">In both JUNV GP1-GP2 and MACV GP1-GP2, the long and narrow, N-terminal ‘strap’ region (residues 59-89, <xref ref-type="fig" rid="F3">Fig. 3</xref>) and the C-terminal α-helix (α4) of GP1 are visible, whereas they were previously not included in NW-GP1 constructs used for structural studies. However, no electron density corresponding to the loops at the C-termini of GP1, which are N-terminal to the cut furin cleavage sites, was observed, suggesting they are intrinsically flexible or may require the formation of higher-order trimers for stabilization.</p><p id="P12">In our crystallized structures, MACV GP2 and JUNV GP2 exhibit the predominantly a-helical class-I pre-fusion fold presented by OW arenaviruses composed of N-terminal and internal fusion peptides, heptad repeat (HR) region 1 (subdivided into subcomponents a-d), T-loop, and HR region 2 (<xref ref-type="fig" rid="F1">Fig. 1</xref>). Unlike the pronounced structural differences between OW and NW GP1s in the GP2 attached states (<xref ref-type="fig" rid="F2">Fig. 2</xref>) the structures of OW and NW GP2 glycoproteins, in their pre-fusion GP1-bound states, are similar (~1.9 Å RMSD). Structural deviation is highest at the C-terminal α-helix of the NW GP2 ectodomain (α9 in JUNV), where it assumes a similar orientation to that observed in trimeric LASV ectodomains (PDB ID 5VK2) but contrasts the membrane-anchored LASV GP spike (PDB ID 7PUY). Overall, the high level of structural conservation across the mammarenavirus GP2 is consistent with the evolutionarily conserved functionality of this subcomponent of the GP.</p><p id="P13">The engineered GP1-GP2 disulfide bonds in JUNV GP1<sup>88-329</sup>GP2<sup>e</sup> and MACV GP1<sup>88-340</sup>GP2<sup>e</sup> structures are occluded within their respective GP1-GP2 interfaces, where they are shielded by the loops they connect (α1-β2 and α6-α7 in JUNV) (<xref ref-type="fig" rid="F1">Fig. 1C</xref>). The GP1 cysteine locates to the loop connecting the strap region with the central β-sheet, whilst the cognate cysteine in GP2 locates to HR1c, which is helical in reported LASV and LCMV GP1-GP2 structures (α9 of LASV, <bold>Supplementary Fig. S4</bold>). Interestingly, however, in the JUNV GP1<sup>88-329</sup>GP2<sup>e</sup> and MACV GP1<sup>88-340</sup>GP2<sup>e</sup> complex structures, only a small portion of the HR1c region is helical and JUNV Cys329 and MACV Cys340 reside within a loop that follows a helix-like trajectory.</p><p id="P14">In JUNV GP1-GP2, insect (<italic>Spodoptera</italic>) cell-derived glycosylation corresponding to paucimannose hybrid-type glycans was well ordered at three out of four N-linked glycosylation sequons (NXS/T, X≠P) of the GP1 subunit (Asn95, Asn166, and Asn178), and at two out of four sites (Asn357 and Asn365) on GP2. Glycosylation at all five and three out of four glycosylation sequons was observed in the GP1 and GP2 subunits of MACV GP1-GP2, respectively (<xref ref-type="fig" rid="F1">Fig. 1</xref>). The extensive glycosylation of GP1 Asn95 in JUNV GP1-GP2 contrasts that observed in reported JUNV GP1 structures and may be attributed to stabilizing interactions imparted by GP2, or to the effect that construct boundaries and the expression system may have on glycan biosynthesis (<bold>Supplementary Fig. S5</bold>). Given the importance of glycans in epitope shielding of the arenavirus surface (<xref ref-type="bibr" rid="R47">47</xref>, <xref ref-type="bibr" rid="R48">48</xref>), occupancy of N-linked sites constitutes an important consideration in the design of immunogens capable of accurately representing the antigenic GP.</p></sec><sec id="S5"><title>NW GP1 N-terminal strap interacts extensively with the GP2</title><p id="P15">The GP1-GP2 interfaces of JUNV and MACV structures occlude ~2,250 Å<sup>2</sup> and ~2,170 Å<sup>2</sup> of surface area, respectively (<xref ref-type="bibr" rid="R49">49</xref>) and are stabilized by extensive hydrophobic interactions, and 7 and 8 hydrogen bonds, respectively. This level of occlusion is similar to that observed in OW GP1-GP2 interactions (~2,350 Å<sup>2</sup> and 2,460 Å<sup>2</sup> for LASV, PDB ID 7PUY, and LCMV, PDB ID 8DMI, respectively). The N-terminal strap, which consists of two β-strands (β1-2), a small α-helix (α1), and a C-terminal loop region preceding the central β-sheet in GP1 (<xref ref-type="fig" rid="F1">Figs. 1</xref> and <xref ref-type="fig" rid="F3">3</xref>, <bold>Supplementary Fig. S6</bold>), contributes the bulk of interactions with GP2, both in the JUNV (~1,420 Å<sup>2</sup> occluded surface) and MACV (~1,380 Å<sup>2</sup>) structure.</p><p id="P16">The N-terminus of the strap region exhibits notable differences between OW and NW GPs in size, orientation, and how it connects to the C-terminal helix of GP2<sup>e</sup> (<xref ref-type="fig" rid="F3">Fig. 3C</xref>). In JUNV, this connection is largely defined by a tryptophan in the C-terminal (α9) helix (Trp395), which is strictly conserved amongst NW-viruses. In OW-viruses, Trp395 is invariably replaced by an isoleucine (LASV GP2<sup>Ile403</sup>), rationalizing the differential binding employed by the strap compared to NW viruses (<xref ref-type="fig" rid="F3">Fig. 3C</xref>, <bold>Supplementary Fig. S6</bold>). This is also reflected in the strap sequences, where many of the GP2-interacting residues in JUNV and MACV are well conserved amongst other NW viruses, but not shared with OW viruses (<bold>Supplementary Fig. S6</bold>).</p><p id="P17">The main β-strand (β2) of the NW GP1 strap occupies a long and deep groove that traverses the outward-facing surface of GP2, joining the GP2 ‘T-loop’ b-strands (<xref ref-type="bibr" rid="R35">35</xref>) at the bottom of the groove to form a narrow but elongated antiparallel β-sheet. The β-turn (Leu66-His67) that connects b1 and b2 is located at a similar position to that in LASV GP, where it was shown to interact with the extracellular region of the SSP of the same protomer (<xref ref-type="bibr" rid="R14">14</xref>). In addition to main-chain hydrogen bonds between the β2 and β12/β13 strands, a series of conserved, hydrophobic interactions between GP1 and GP2 are observed, notably involving Phe70 and Phe75 (<xref ref-type="fig" rid="F3">Fig. 3B, C</xref>).</p><p id="P18">The Phe75-containing loop preceding the α1-helix of the strap interacts at several points with the so called ‘internal’ segment of the fusion peptide (i-FPS (<xref ref-type="bibr" rid="R25">25</xref>)) via a series of main-and side-chain interactions (<xref ref-type="fig" rid="F4">Fig. 4A, B</xref>). This arrangement suggests that dislodgment of the strap and the liberation of the fusion peptide in the endosomes are part of the same process. In line with this, the α1-helix and a short stretch of residues following the loop are linked to the N-terminal segment of the FPS, albeit indirectly, via a6 of GP2.</p><p id="P19">The α1 helix (<xref ref-type="bibr" rid="R77">77</xref>-82) assumes different orientations in the JUNV and MACV GP1-GP2 complex structures (<xref ref-type="fig" rid="F4">Fig. 4</xref>). Additionally, and possibly related to this observation, the neighboring Asn83 in MACV GP1 is glycosylated and directed away from the GP2-resident fusion peptide (<xref ref-type="fig" rid="F4">Fig. 4C</xref>). Asn83 is part of a four-residue extension of the α1-β3 loop that is found in a small subset of clade B NW viruses, including JUNV, MACV, Tacaribe virus (TCRV), Tietê virus (<xref ref-type="bibr" rid="R50">50</xref>) and Ocozocoautla de Espinosa virus (OCEV) (<bold>Supplementary Fig. S6</bold>) (<xref ref-type="bibr" rid="R51">51</xref>). Although Asn83 is conserved amongst these viruses, only in MACV, TCRV and Tietê virus is it part of an NXS/T (where X≠P) N-linked glycosylation sequon. Interestingly, however, an NXS/T motif is commonly found at a similar location in OW viruses, C-terminal of the 3<sub>10</sub>-helix replacing MACV GP1 α1 (<bold>Supplementary Fig. S6</bold>). Similar to Asn83 in MACV, the corresponding Asn-residues in LASV (Asn79, PDB ID 5VK2) and LCMV (Asn85, PDB ID 8DMI) were observed to be glycosylated and directed away from the fusion peptide, indicative of a conserved structural feature across these distant arenaviral glycoproteins.</p></sec><sec id="S6"><title>The NW GP1-GP2 interface at the α3- and α4-helices</title><p id="P20">Both α3- and α4-helices of GP1 contribute to the NW GP1-GP2 interface (<xref ref-type="fig" rid="F5">Fig. 5</xref>). For example, inter-subunit interactions occur between GP1 α3 and residues at and proximal to α8 of GP2. In JUNV GP1-GP2, this includes notable hydrogen bonds between Arg201 and the side chain and N-acetylglucosamine moieties of Asn357 (<xref ref-type="fig" rid="F5">Fig. 5D</xref>). The α4-helix of the C-terminus of GP1 is located centrally in the GP1-GP2 interfaces. In addition to forming intra-subunit interactions with α1 of the strap, α4 is strongly embedded in the globular part of GP1 (<xref ref-type="fig" rid="F5">Fig. 5A-C</xref>). Facing GP2, α4 wedges between Heptad Repeat (HR) regions 1c (α7) and 1d (α8) (<xref ref-type="bibr" rid="R30">30</xref>), which may sterically impede the formation of the continuous α-helix observed in the post-fusion conformation of GP2 (<xref ref-type="fig" rid="F5">Fig. 5B</xref>).</p></sec><sec id="S7"><title>The elongated morphology of JUNV and MACV GP1-GP2s</title><p id="P21">As described above, the conserved GP2<sup>e</sup> subunits of JUNV and MACV share a high level of structural similarity with those of reported LASV structures (PDB codes 7PUY and 5VK2). However, upon superposition of the GP2 cores, we observe differences in the positions of the GP1s, relative to their cognate GP2s. Whilst maintaining the same orientation, the central β-sheets of the JUNV and MACV GP1s are at a greater distance from the GP2s than in LASV and LCMV GP1-GP2 structures (<xref ref-type="fig" rid="F6">Fig. 6A</xref>). The relative ‘upward’ shift of the NW GP1, with respect to OW GP1, may be attributed, in part, to a four-residue extension of the loop following the α1 helix (<bold>Supplementary Fig. S6</bold>). This loop tethers the β-sheet to the GP2-embedded strap region. Given that only a small subset of clade B arenaviruses encode this loop extension, it is unlikely that the shift is a common feature among NW viruses (<bold>Supplementary Fig. S6</bold>). The upward shift, combined with the enlargement of α3 by the η2 helix, the addition of a strand (β6) to the sheet, and the protrusion of the β5-β6 and β7-β8 connecting loops from the apex of the GP1 fold, result in the observed elongated morphology of JUNV and MACV GP1-GP2 complexes, with respect to LASV GP1-GP2 (<xref ref-type="fig" rid="F6">Fig. 6A</xref>). Accordingly, the distance between the membrane-proximal β1-β2 turn and the most apical GP1 residue is 80 Å in JUNV, compared to 70 Å in LASV. The extra β6-strand of GP1 may be a conserved characteristic of NW arenaviruses, where the loop containing it is generally much longer than in OW viruses (<bold>Supplementary Fig. S4</bold>).</p><p id="P22">In JUNV, η1 and α2 assume a different orientation from that of the corresponding helices in LASV, where they demarcate a groove that acts as a binding site for the SKI-loop of a neighboring GP1 (<xref ref-type="bibr" rid="R14">14</xref>). A similar, well-defined groove is not obvious in our JUNV or MACV GP1-GP2 structures (<xref ref-type="fig" rid="F7">Fig. 7A</xref>). Binding of SKI-loops in the native trimers of these viruses may thus involve a different set of interactions and a different trajectory of the loops, as is plausible in our model of the trimeric NW GP (<xref ref-type="fig" rid="F7">Fig. 7B</xref>). This variation reflects the low level of sequence conservation of the SKI-loop amongst mammarenaviruses, where only the P4 residue of the cleavage site (Arg248 in JUNV, Arg256 in LASV) is strictly conserved.</p></sec></sec><sec id="S8" sec-type="discussion"><title>Discussion</title><p id="P23">Our inability to protect against the unpredictable emergence of New World arenaviruses constitutes a substantial risk to human health and economy (<xref ref-type="bibr" rid="R52">52</xref>). Indeed, although Candid#1 protects against JUNV (<xref ref-type="bibr" rid="R6">6</xref>), the use of this vaccine is limited and there is a paucity of therapeutics capable of protecting against this and other zoonotic New World arenaviruses.</p><p id="P24">Neutralizing antibodies arising from infection are predominantly elicited against the NW GP (<xref ref-type="bibr" rid="R7">7</xref>, <xref ref-type="bibr" rid="R39">39</xref>, <xref ref-type="bibr" rid="R48">48</xref>). To better understand this key antiviral and vaccine target, NW GP1 and GP2 fragments have been subjected to high resolution structural studies, alone and in complex with receptors and Fab fragments of neutralizing antibodies (<xref ref-type="bibr" rid="R39">39</xref>–<xref ref-type="bibr" rid="R43">43</xref>). Despite the insights gleaned from these combined works, molecular-level detail of how these GP subcomponents assemble has remained elusive. Here, through elucidation of the GP1-GP2 heterodimeric architecture from the re-emerging and highly pathogenic JUNV and MACV, we refine our understanding of a key building block of the trimeric NW GP.</p><p id="P25">This work was dependent upon our ability to produce suitable amounts of metastable GP1-GP2 and required the incorporation of unique site-direct point mutations that help stabilize and maintain the pre-fusion conformation of the heterodimeric complex. Such an approach builds upon previous successes in introducing disulfide bond bridges to stabilize immunogens against other important pathogens, including LASV (<xref ref-type="bibr" rid="R13">13</xref>), foot-and-mouth disease virus (<xref ref-type="bibr" rid="R53">53</xref>), respiratory syncytial virus (<xref ref-type="bibr" rid="R54">54</xref>) and human metapneumovirus (<xref ref-type="bibr" rid="R55">55</xref>). Assessment of whether our NW GP1-GP2 constructs, when incorporated into immunogens, enhance the potency and breadth of the neutralizing immune response beyond that already demonstrated through immunization with GP1 fragments, will inform upon the development of next-generation vaccines.</p><p id="P26">Our incorporated disulfide bond links the loop preceding the central β-sheet of GP1 with the HR1c region of GP2. This linkage is at a different location from that used to stabilize OW virus GPs which connects the long α4-β8 loop of GP1 to the C-terminus of HR1d (<xref ref-type="bibr" rid="R13">13</xref>). Although we cannot preclude the possibility that our added disulfide bridge may impede proper formation of the HR1c helix, this region is occluded by the HR1b-loop and is therefore unlikely to markedly alter the antigenicity of the glycoprotein. Furthermore, our derived constructs are antigenically relevant and recognized by previously reported immunization-derived neutralizing monoclonal antibodies (<xref ref-type="bibr" rid="R39">39</xref>). Interestingly, we find that unlike the GP2-free state of OW LASV GP1, which when secreted has a putative role as an immune decoy (<xref ref-type="bibr" rid="R56">56</xref>), NW GP1 structures are highly similar between GP2-bound and GP2-free states.</p><p id="P27">Whether the JUNV GP1-GP2 and MACV GP1-GP2 structures described here are fully representative of the wider NW arenavirus lineage is uncertain. It is possible that the elongated shape of JUNV GP1-GP2 and MACV GP1-GP2, compared to OW virus GPs, may be more pronounced in the subset of clade B viruses that have a longer loop between the strap region and central β-sheet of the GP1. Indeed, other NW virus GPs may display a more compact fold that more closely resembles the morphology of OW arenavirus GPs. This hypothesis is especially plausible for the GPs of clade C viruses, which use α-dystroglycan as a cellular receptor and have SKI-1 site residues that are well conserved with OW arenaviruses, suggesting they may also interact with matriglycan groups (<xref ref-type="bibr" rid="R14">14</xref>).</p><p id="P28">Understanding the high-resolution structures of the glycoproteins presented by zoonotic arenaviruses constitutes a key step in the rational design of therapeutics that can increase our pandemic preparedness. While future efforts will no doubt focus on the engineering of homogeneously processed trimeric NW glycoproteins that present native-like glycosylation, this work provides much-needed molecular-level blueprints for the rational development of vaccines against newly and re-emerging NW arenaviruses.</p></sec><sec id="S9" sec-type="materials | methods"><title>Materials and methods</title><sec id="S10"><title>Strains</title><p id="P29">Accession codes and abbreviations are defined, as follows: ACO52428 (JUNV; <italic>M. juninense</italic>; Junín virus, XJ13 strain), AAN05425 (MACV; <italic>M. machupoense</italic>; Machupo virus, strain Carvallo), YP_089665 (SABV; <italic>M. brazilense</italic>; Sabiá virus); YP_001816782 (CHAPV; <italic>M. chapareense</italic>; Chapare virus), YP_001911113 (WWAV; <italic>M. whitewaterense</italic>, Whitewater Arroyo virus), YP_001649210 (OLVV; <italic>M. oliverosense</italic>; Oliveros virus), AAC32281 (PICHV, <italic>M. caliense</italic>; Pichindé virus), NP_694870 (LASV), P09991(LCMV), YP_002929490 (LUJV; <italic>M.. Lujoense</italic>; Lujo virus), AY129247 (GTOV; <italic>M. guanoritaense</italic>; Guanarito virus), UZO33083 (Tietê mammarenavirus), A0A023J4Z7 (LORV, <italic>M. loeiense</italic>, Loei river virus), AAN09948 (<italic>M. tamiamiensi</italic>: Tamiami virus), AAN32957 (<italic>M. paranaense</italic>; Paraná virus), AAG42529.1 (<italic>M.</italic> <italic>allpahuayoense</italic>; Allpahuayo virus), BAL03415 (<italic>M. lunaense</italic>; Luna virus), YP_009116790 (<italic>M. gairoense</italic>; Gairo virus), ABU94343 (Tonto creek virus), ABI97298 (Catarina virus), ABW96596 (Skinner Tank virus), YP_001649222 (<italic>M. cupixiense</italic>; Cupixi virus), YP_009553321 (Aporé virus), P31842 (TCRV; <italic>M. tacaribeense</italic>; Tacaribe virus), YP_010086246 (Xapuri virus), AFD98839 (OCEV; Ocozocoautla de Espinosa virus), YP_001649226 (<italic>M. bearense</italic>; Bear Canyon virus), AAT88084 (<italic>M. piritalense</italic>; Pirital virus), Q8B121 (<italic>M.latinum</italic>; Latino virus), P19240 (<italic>M. mopeiaense</italic>; Mopeia virus), YP_516226 (<italic>M. praomyidis</italic>; Mobala virus), AAN32967 (Amapari virus), QWQ58032 (Bitu virus), QLJ57221 (Dhati Welel virus), YP_010840421 (Kwanza virus), YP_010839773 (Alxa virus), AUF72664 (<italic>M. wenzhouense</italic>; Wenzhou virus), YP_001936019 (<italic>M. flexalense</italic>; Flexal virus), ADX32836 (Gbagroube virus), ADX32840 (Menekre virus), YP_009141005 (<italic>M. okahandjaense</italic>; Okahandja virus).</p></sec><sec id="S11"><title>Cloning</title><p id="P30">All enzymes were purchased from New England Biolabs. Synthetic DNAs were obtained from Geneart (ThermoFisher Scientific) and ligated into a modified pOPIN-vector (<xref ref-type="bibr" rid="R57">57</xref>, <xref ref-type="bibr" rid="R58">58</xref>), putting them downstream of a p10 promotor and adding an enterokinase site and a Twin-Strep tag (<xref ref-type="bibr" rid="R59">59</xref>) to the C-terminus of the translation product. PCR-based mutagenesis was used to introduce stabilizing disulfide bonds and to alter the SKI-1 substrate peptide into a furin cleavage site. Whereas in the JUNV constructs, the replacement of the Arg-Ser-Leu-Lys SKI-1 site with an Arg-Arg-Arg-Arg peptide resulted in satisfactory furin cleavage, in the MACV GP1-GP2<sup>e</sup>, the residues flanking the SKI-1site needed to be additionally mutated into serines (Glu-Arg-Ser-Leu-Lys-Ala was changed into Ser-Arg-Arg-Lys-Arg-Ser). The sequences of all constructs were confirmed by Sanger sequencing (Eurofins). Plasmids were co-transfected with baculovirus DNA into <italic>Spodoptera frugiperda</italic> (<italic>Sf</italic>9) cells using Cellfectin II (Invitrogen) to generate recombinant baculovirus (<xref ref-type="bibr" rid="R58">58</xref>, <xref ref-type="bibr" rid="R60">60</xref>). The quality of the baculovirus stocks was determined by monitoring cell lysis of infected cells with trypan blue (<xref ref-type="bibr" rid="R61">61</xref>).</p></sec><sec id="S12"><title>Expression and purification</title><p id="P31">Fab constructs were expressed in HEK293T cells as described before (<xref ref-type="bibr" rid="R39">39</xref>). Suspension cultures of baculovirus infected <italic>Sf</italic>9 cells in SF900II medium (Gibco; 27.5 °C, 120 rpm) were used for GP1-GP2<sup>e</sup> production. Four days post-infection, the medium was supplemented with Tris pH 8.0 (to 10 mM) and EDTA (0.5 mM) and clarified (5000 x g, 45 min). BioLock solution (IBA; 2.4 ml/L) was added before the medium was passed over a column containing 0.5-ml Strep-Tactin XT resin (IBA). Resin-bound protein was washed with 100 mM Tris pH 8.0, 500 mM NaCl, 0.5 mM EDTA and eluted with this buffer supplemented with biotin (to 50 mM; Sigma). The eluate was concentrated using a 30 kDa molecular weight cut-off (MWCO) centrifugal filter device (Amicon, Millipore) and submitted to size-exclusion chromatography (SEC) over a Superdex 200 increase 10/300 GL column (Cytiva), using a 15 mM Tris (pH 8.0) running buffer containing 200 mM NaCl and 0.5 mM EDTA.</p><p id="P32">JUNV and MACV GP1-GP2<sup>e</sup> containing fractions were further resolved over a 1-ml HiTRAP SP (HP) column (Cytiva) using a and a linear, 0-500 mM NaCl gradient (over 30 min, at a 1 ml/min flow rate) in a 30 mM Tris pH8.0 running buffer. Protein not retained by the SP column was applied to a 1-ml HiTrap Q column (Cytiva) for fractionation, using the same buffer and NaCl gradient.</p><p id="P33">Purified protein fractions were examined by SDS-PAGE over 4-20% Tris-Glycine gels (NuSep) and by western blotting, in the presence and absence of reducing agent (β-mercaptoethanol), to evaluate purity, disulfide bond formation and furin cleavage. For detection of protein on western blots, horseradish-peroxidase conjugated Strep-Tactin (IBA Lifesciences) was used in combination with luminescent Clarity Western ECL substrate (BioRad). Band intensities were measured using Invitrogen’s iBright analysis software.</p></sec><sec id="S13"><title>Crystallization, data collection, and structure determination</title><p id="P34">JUNV GP1-GP2<sup>e</sup> and MACV GP1-GP2<sup>e</sup> proteins were incubated for 3 h at room temperature with previously characterized, GP1-binding Fabs, termed JUN1 and MAC1, respectively (<xref ref-type="bibr" rid="R39">39</xref>). The resulting complexes were separated from excess Fab protein by SEC (as above). The samples were concentrated, and the buffer exchanged to 10 mM Tris pH 8.0, in 30-kDa MWCO centrifugal filter devices.</p><p id="P35">Crystals were obtained by vapor diffusion at 21 °C. Typically 100 nL of the GP1-GP2<sup>e</sup>-Fab complex (~5mg/ml) was combined with 100 nL of reservoir solution in 96-well sitting drop plates (Greiner), and the mixture was allowed to equilibrate against 90 uL of reservoir solution (<xref ref-type="bibr" rid="R62">62</xref>). Crystals of the JUNV GP1-GP2 complex with JUN1 grew in 20% v/v 2-Propanol, 0.1 M Tris pH 8.0, 5% w/v PEG 8K, 6% 2-Methyl-2,4-pentanediol. The MACV GP1-GP2 complex with MAC1 crystallized in 90 mM Li2SO4, 90 mM Na2SO4, 90 mM K2SO4,12.5 % w/v PEG 4000, 20% w/v 1,2,6-Hexanetriol, 0.1 M Gly-Gly/AMPD pH 8.5. Diamond beamlines I03 and I04-1 (Harwell, UK) were used for diffraction data collection at 100K. Data processing employed the XIA2 suite (<xref ref-type="bibr" rid="R63">63</xref>) and structures were solved with the molecular replacement program PHASER (<xref ref-type="bibr" rid="R64">64</xref>), using previously determined coordinates of the JUNV and MACV GP1 subunits (<xref ref-type="bibr" rid="R39">39</xref>, <xref ref-type="bibr" rid="R41">41</xref>), of the LCMV GP2 subunit (<xref ref-type="bibr" rid="R30">30</xref>) and of the Fabs (<xref ref-type="bibr" rid="R39">39</xref>). COOT (<xref ref-type="bibr" rid="R65">65</xref>) was used for model building, BUSTER (<xref ref-type="bibr" rid="R66">66</xref>) and Phenix (<xref ref-type="bibr" rid="R67">67</xref>) for refinement. Structure validation employed COOT and Molprobity (<xref ref-type="bibr" rid="R68">68</xref>). Data collection and refinement statistics are provided in <bold>Supplementary Table 1</bold>.</p><p id="P36">Figures were prepared using PyMOL Molecular Graphics System (Version 2.1) (<xref ref-type="bibr" rid="R69">69</xref>) and UCSF ChimeraX (<xref ref-type="bibr" rid="R49">49</xref>). ChimeraX was also used to calculate RMSD values. Stride (<xref ref-type="bibr" rid="R70">70</xref>) was used for secondary structure assignment. Fab residues were numbered using the Martin scheme of the Abnum numbering program (<xref ref-type="bibr" rid="R71">71</xref>).</p><p id="P37">Protein alignments were obtained using T-coffee (<xref ref-type="bibr" rid="R72">72</xref>) and visualised with ESPript 3.0 (<xref ref-type="bibr" rid="R73">73</xref>). Interactions were identified using PLIP (<xref ref-type="bibr" rid="R74">74</xref>).</p></sec><sec id="S14"><title>Structure-based classification analysis</title><p id="P38">For structural-based classification, the protein databank files of NW and OW GP1 monomers were prepared by removal of water molecules, ligands, and protein residues outside of the canonical fold. Structures were analyzed with the Structural Homology Program, SHP (<xref ref-type="bibr" rid="R75">75</xref>–<xref ref-type="bibr" rid="R77">77</xref>). Pairwise evolutionary distance matrices were used to generate un-rooted phylogenetic trees in PHYLIP (<xref ref-type="bibr" rid="R78">78</xref>).</p></sec><sec id="S15"><title>Data deposition</title><p id="P39">The atomic coordinates and structure factors for JUNV GP1<sup>88-329</sup>GP2<sup>e</sup> and MACV GP1<sup>88-340</sup>GP2<sup>e</sup> complexes with the Fab fragments of GP1-targeting neutralizing mAbs, JUN1 and MAC1, have been deposited in the Protein Data Bank with the accession codes 9GHJ and 9GHI, respectively.</p></sec></sec></body><back><ack id="S16"><title>Acknowledgements</title><p>The authors would like to thank Diamond Light Source (Harwell, UK) for beamtime (proposals 19946 and mx28534), and the I03 and I04-1 beamline staff for assistance with data collection. We thank Daniel Pinschewer and Mehmet Sahin for their collaboration, which helped to generate the mAbs, JUN1 and MAC1. This work was funded by Medical Research Council MR/L009528/1 and MR/S007555/1 (to T.A.B.), and MR/N002091/1 and MR/V031635/1 (to T.A.B. and K.J.D.). W.M.N is supported by the Wellcome Early Career Award 226997/Z/23/Z. The Centre for Human Genetics was supported by the Wellcome grant 203141/Z/16/Z.</p></ack><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Charrel</surname><given-names>RN</given-names></name><name><surname>de Lamballerie</surname><given-names>X</given-names></name></person-group><article-title>Zoonotic aspects of arenavirus infections</article-title><source>Vet Microbiol</source><year>2010</year><volume>140</volume><fpage>213</fpage><lpage>220</lpage><pub-id pub-id-type="pmid">19748747</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grande-Perez</surname><given-names>A</given-names></name><name><surname>Martin</surname><given-names>V</given-names></name><name><surname>Moreno</surname><given-names>H</given-names></name><name><surname>de la Torre</surname><given-names>JC</given-names></name></person-group><article-title>Arenavirus Quasispecies and Their Biological Implications</article-title><source>Curr Top Microbiol Immunol</source><year>2016</year><volume>392</volume><fpage>231</fpage><lpage>276</lpage><pub-id pub-id-type="pmcid">PMC7122398</pub-id><pub-id pub-id-type="pmid">26472215</pub-id><pub-id pub-id-type="doi">10.1007/82_2015_468</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mylne</surname><given-names>AQ</given-names></name><etal/></person-group><article-title>Mapping the zoonotic niche of Lassa fever in Africa</article-title><source>Trans R Soc Trop Med Hyg</source><year>2015</year><volume>109</volume><fpage>483</fpage><lpage>492</lpage><pub-id pub-id-type="pmcid">PMC4501400</pub-id><pub-id pub-id-type="pmid">26085474</pub-id><pub-id pub-id-type="doi">10.1093/trstmh/trv047</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albarino</surname><given-names>CG</given-names></name><etal/></person-group><article-title>High diversity and ancient common ancestry of lymphocytic choriomeningitis virus</article-title><source>Emerg Infect Dis</source><year>2010</year><volume>16</volume><fpage>1093</fpage><lpage>1100</lpage><pub-id pub-id-type="pmcid">PMC3321910</pub-id><pub-id pub-id-type="pmid">20587180</pub-id><pub-id pub-id-type="doi">10.3201/eid1607.091902</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hallam</surname><given-names>SJ</given-names></name><name><surname>Koma</surname><given-names>T</given-names></name><name><surname>Maruyama</surname><given-names>J</given-names></name><name><surname>Paessler</surname><given-names>S</given-names></name></person-group><article-title>Review of Mammarenavirus Biology and Replication</article-title><source>Frontiers in Microbiology</source><year>2018</year><volume>9</volume><pub-id pub-id-type="pmcid">PMC6085440</pub-id><pub-id pub-id-type="pmid">30123198</pub-id><pub-id pub-id-type="doi">10.3389/fmicb.2018.01751</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gowen</surname><given-names>BB</given-names></name><etal/></person-group><article-title>Second-Generation Live-Attenuated Candid#1 Vaccine Virus Resists Reversion and Protects against Lethal Junin Virus Infection in Guinea Pigs</article-title><source>J Virol</source><year>2021</year><volume>95</volume><elocation-id>e0039721</elocation-id><pub-id pub-id-type="pmcid">PMC8223921</pub-id><pub-id pub-id-type="pmid">33952638</pub-id><pub-id pub-id-type="doi">10.1128/JVI.00397-21</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crispin</surname><given-names>M</given-names></name><name><surname>Zeltina</surname><given-names>A</given-names></name><name><surname>Zitzmann</surname><given-names>N</given-names></name><name><surname>Bowden</surname><given-names>TA</given-names></name></person-group><article-title>Native functionality and therapeutic targeting of arenaviral glycoproteins</article-title><source>Curr Opin Virol</source><year>2016</year><volume>18</volume><fpage>70</fpage><lpage>75</lpage><pub-id pub-id-type="pmcid">PMC4983490</pub-id><pub-id pub-id-type="pmid">27104809</pub-id><pub-id pub-id-type="doi">10.1016/j.coviro.2016.04.001</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burri</surname><given-names>DJ</given-names></name><etal/></person-group><article-title>Molecular characterization of the processing of arenavirus envelope glycoprotein precursors by subtilisin kexin isozyme-1/site-1 protease</article-title><source>J Virol</source><year>2012</year><volume>86</volume><fpage>4935</fpage><lpage>4946</lpage><pub-id pub-id-type="pmcid">PMC3347368</pub-id><pub-id pub-id-type="pmid">22357276</pub-id><pub-id pub-id-type="doi">10.1128/JVI.00024-12</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rojek</surname><given-names>JM</given-names></name><name><surname>Kunz</surname><given-names>S</given-names></name></person-group><article-title>Cell entry by human pathogenic arenaviruses</article-title><source>Cell Microbiol</source><year>2008</year><volume>10</volume><fpage>828</fpage><lpage>835</lpage><pub-id pub-id-type="pmid">18182084</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hulswit</surname><given-names>RJG</given-names></name><name><surname>Paesen</surname><given-names>GC</given-names></name><name><surname>Bowden</surname><given-names>TA</given-names></name><name><surname>Shi</surname><given-names>X</given-names></name></person-group><article-title>Recent Advances in Bunyavirus Glycoprotein Research: Precursor Processing, Receptor Binding and Structure</article-title><source>Viruses</source><year>2021</year><volume>13</volume><pub-id pub-id-type="pmcid">PMC7926653</pub-id><pub-id pub-id-type="pmid">33672327</pub-id><pub-id pub-id-type="doi">10.3390/v13020353</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Pasquato</surname><given-names>A</given-names></name><name><surname>Cendron</surname><given-names>L</given-names></name><name><surname>Kunz</surname><given-names>S</given-names></name></person-group><chapter-title>Cleavage of the Glycoprotein of Arenaviruses</chapter-title><person-group person-group-type="editor"><name><surname>Böttcher-Friebertshäuser</surname><given-names>E</given-names></name><name><surname>Garten</surname><given-names>W</given-names></name><name><surname>Klenk</surname><given-names>HD</given-names></name></person-group><source>Activation of Viruses by Host Proteases</source><publisher-name>Springer International Publishing</publisher-name><publisher-loc>Cham</publisher-loc><year>2018</year><fpage>47</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1007/978-3-319-75474-1_3</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rojek</surname><given-names>JM</given-names></name><name><surname>Lee</surname><given-names>AM</given-names></name><name><surname>Nguyen</surname><given-names>N</given-names></name><name><surname>Spiropoulou</surname><given-names>CF</given-names></name><name><surname>Kunz</surname><given-names>S</given-names></name></person-group><article-title>Site 1 protease is required for proteolytic processing of the glycoproteins of the South American hemorrhagic fever viruses Junin, Machupo, and Guanarito</article-title><source>J Virol</source><year>2008</year><volume>82</volume><fpage>6045</fpage><lpage>6051</lpage><pub-id pub-id-type="pmcid">PMC2395157</pub-id><pub-id pub-id-type="pmid">18400865</pub-id><pub-id pub-id-type="doi">10.1128/JVI.02392-07</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hastie</surname><given-names>KM</given-names></name><etal/></person-group><article-title>Structural basis for antibody-mediated neutralization of Lassa virus</article-title><source>Science</source><year>2017</year><volume>356</volume><fpage>923</fpage><lpage>928</lpage><pub-id pub-id-type="pmcid">PMC6007842</pub-id><pub-id pub-id-type="pmid">28572385</pub-id><pub-id pub-id-type="doi">10.1126/science.aam7260</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katz</surname><given-names>M</given-names></name><etal/></person-group><article-title>Structure and receptor recognition by the Lassa virus spike complex</article-title><source>Nature</source><year>2022</year><pub-id pub-id-type="pmid">35173332</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zong</surname><given-names>M</given-names></name><name><surname>Fofana</surname><given-names>I</given-names></name><name><surname>Choe</surname><given-names>H</given-names></name></person-group><article-title>Human and host species transferrin receptor 1 use by North American arenaviruses</article-title><source>J Virol</source><year>2014</year><volume>88</volume><fpage>9418</fpage><lpage>9428</lpage><pub-id pub-id-type="pmcid">PMC4136298</pub-id><pub-id pub-id-type="pmid">24920811</pub-id><pub-id pub-id-type="doi">10.1128/JVI.01112-14</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kunz</surname><given-names>S</given-names></name><name><surname>Borrow</surname><given-names>P</given-names></name><name><surname>Oldstone</surname><given-names>MB</given-names></name></person-group><article-title>Receptor structure, binding, and cell entry of arenaviruses</article-title><source>Curr Top Microbiol Immunol</source><year>2002</year><volume>262</volume><fpage>111</fpage><lpage>137</lpage><pub-id pub-id-type="pmid">11987803</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burri</surname><given-names>DJ</given-names></name><name><surname>da Palma</surname><given-names>JR</given-names></name><name><surname>Kunz</surname><given-names>S</given-names></name><name><surname>Pasquato</surname><given-names>A</given-names></name></person-group><article-title>Envelope glycoprotein of arenaviruses</article-title><source>Viruses</source><year>2012</year><volume>4</volume><fpage>2162</fpage><lpage>2181</lpage><pub-id pub-id-type="pmcid">PMC3497046</pub-id><pub-id pub-id-type="pmid">23202458</pub-id><pub-id pub-id-type="doi">10.3390/v4102162</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moreno</surname><given-names>H</given-names></name><etal/></person-group><article-title>A novel circulating tamiami mammarenavirus shows potential for zoonotic spillover</article-title><source>PLoS Negl Trop Dis</source><year>2020</year><volume>14</volume><elocation-id>e0009004</elocation-id><pub-id pub-id-type="pmcid">PMC7794035</pub-id><pub-id pub-id-type="pmid">33370288</pub-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0009004</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>W</given-names></name><etal/></person-group><article-title>Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus</article-title><source>Science</source><year>1998</year><volume>282</volume><fpage>2079</fpage><lpage>2081</lpage><pub-id pub-id-type="pmid">9851928</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radoshitzky</surname><given-names>SR</given-names></name><etal/></person-group><article-title>Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses</article-title><source>Nature</source><year>2007</year><volume>446</volume><fpage>92</fpage><lpage>96</lpage><pub-id pub-id-type="pmcid">PMC3197705</pub-id><pub-id pub-id-type="pmid">17287727</pub-id><pub-id pub-id-type="doi">10.1038/nature05539</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raaben</surname><given-names>M</given-names></name><etal/></person-group><article-title>NRP2 and CD63 Are Host Factors for Lujo Virus Cell Entry</article-title><source>Cell Host Microbe</source><year>2017</year><volume>22</volume><fpage>688</fpage><lpage>696</lpage><elocation-id>e685</elocation-id><pub-id pub-id-type="pmcid">PMC5821226</pub-id><pub-id pub-id-type="pmid">29120745</pub-id><pub-id pub-id-type="doi">10.1016/j.chom.2017.10.002</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amanat</surname><given-names>F</given-names></name><etal/></person-group><article-title>Antibodies to the Glycoprotein GP2 Subunit Cross-React between Old and New World Arenaviruses</article-title><source>mSphere</source><year>2018</year><volume>3</volume><pub-id pub-id-type="pmcid">PMC5932378</pub-id><pub-id pub-id-type="pmid">29720525</pub-id><pub-id pub-id-type="doi">10.1128/mSphere.00189-18</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen-Dvashi</surname><given-names>H</given-names></name><name><surname>Israeli</surname><given-names>H</given-names></name><name><surname>Shani</surname><given-names>O</given-names></name><name><surname>Katz</surname><given-names>A</given-names></name><name><surname>Diskin</surname><given-names>R</given-names></name></person-group><article-title>Role of LAMP1 Binding and pH Sensing by the Spike Complex of Lassa Virus</article-title><source>J Virol</source><year>2016</year><volume>90</volume><fpage>10329</fpage><lpage>10338</lpage><pub-id pub-id-type="pmcid">PMC5105667</pub-id><pub-id pub-id-type="pmid">27605678</pub-id><pub-id pub-id-type="doi">10.1128/JVI.01624-16</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakkers</surname><given-names>MJG</given-names></name><etal/></person-group><article-title>CD164 is a host factor for lymphocytic choriomeningitis virus entry</article-title><source>Proc Natl Acad Sci U S A</source><year>2022</year><volume>119</volume><elocation-id>e2119676119</elocation-id><pub-id pub-id-type="pmcid">PMC8915965</pub-id><pub-id pub-id-type="pmid">35235462</pub-id><pub-id pub-id-type="doi">10.1073/pnas.2119676119</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klewitz</surname><given-names>C</given-names></name><name><surname>Klenk</surname><given-names>HD</given-names></name><name><surname>Ter Meulen</surname><given-names>J</given-names></name></person-group><article-title>Amino acids from both N-terminal hydrophobic regions of the Lassa virus envelope glycoprotein GP-2 are critical for pH-dependent membrane fusion and infectivity</article-title><source>J Gen Virol</source><year>2007</year><volume>88</volume><fpage>2320</fpage><lpage>2328</lpage><pub-id pub-id-type="pmid">17622638</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>JM</given-names></name><name><surname>Delos</surname><given-names>SE</given-names></name><name><surname>Brecher</surname><given-names>M</given-names></name><name><surname>Schornberg</surname><given-names>K</given-names></name></person-group><article-title>Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme</article-title><source>Crit Rev Biochem Mol Biol</source><year>2008</year><volume>43</volume><fpage>189</fpage><lpage>219</lpage><pub-id pub-id-type="pmcid">PMC2649671</pub-id><pub-id pub-id-type="pmid">18568847</pub-id><pub-id pub-id-type="doi">10.1080/10409230802058320</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>S</given-names></name><etal/></person-group><article-title>Acidic pH-Induced Conformations and LAMP1 Binding of the Lassa Virus Glycoprotein Spike</article-title><source>PLoS Pathog</source><year>2016</year><volume>12</volume><elocation-id>e1005418</elocation-id><pub-id pub-id-type="pmcid">PMC4743923</pub-id><pub-id pub-id-type="pmid">26849049</pub-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1005418</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hastie</surname><given-names>KM</given-names></name><etal/></person-group><article-title>Convergent Structures Illuminate Features for Germline Antibody Binding and Pan-Lassa Virus Neutralization</article-title><source>Cell</source><year>2019</year><volume>178</volume><fpage>1004</fpage><lpage>1015</lpage><elocation-id>e1014</elocation-id><pub-id pub-id-type="pmcid">PMC6814208</pub-id><pub-id pub-id-type="pmid">31398326</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2019.07.020</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enriquez</surname><given-names>AS</given-names></name><etal/></person-group><article-title>Delineating the mechanism of anti-Lassa virus GPC-A neutralizing antibodies</article-title><source>Cell Rep</source><year>2022</year><volume>39</volume><elocation-id>110841</elocation-id><pub-id pub-id-type="pmcid">PMC9258627</pub-id><pub-id pub-id-type="pmid">35613585</pub-id><pub-id pub-id-type="doi">10.1016/j.celrep.2022.110841</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hastie</surname><given-names>KM</given-names></name><etal/></person-group><article-title>Crystal structure of the prefusion surface glycoprotein of the prototypic arenavirus LCMV</article-title><source>Nat Struct Mol Biol</source><year>2016</year><volume>23</volume><fpage>513</fpage><lpage>521</lpage><pub-id pub-id-type="pmcid">PMC4945123</pub-id><pub-id pub-id-type="pmid">27111888</pub-id><pub-id pub-id-type="doi">10.1038/nsmb.3210</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen-Dvashi</surname><given-names>H</given-names></name><name><surname>Cohen</surname><given-names>N</given-names></name><name><surname>Israeli</surname><given-names>H</given-names></name><name><surname>Diskin</surname><given-names>R</given-names></name></person-group><article-title>Molecular Mechanism for LAMP1 Recognition by Lassa Virus</article-title><source>J Virol</source><year>2015</year><volume>89</volume><fpage>7584</fpage><lpage>7592</lpage><pub-id pub-id-type="pmcid">PMC4505663</pub-id><pub-id pub-id-type="pmid">25972533</pub-id><pub-id pub-id-type="doi">10.1128/JVI.00651-15</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pryce</surname><given-names>R</given-names></name><etal/></person-group><article-title>Structure-Based Classification Defines the Discrete Conformational Classes Adopted by the Arenaviral GP1</article-title><source>J Virol</source><year>2019</year><volume>93</volume><pub-id pub-id-type="pmcid">PMC6288339</pub-id><pub-id pub-id-type="pmid">30305351</pub-id><pub-id pub-id-type="doi">10.1128/JVI.01048-18</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen-Dvashi</surname><given-names>H</given-names></name><name><surname>Kilimnik</surname><given-names>I</given-names></name><name><surname>Diskin</surname><given-names>R</given-names></name></person-group><article-title>Structural basis for receptor recognition by Lujo virus</article-title><source>Nat Microbiol</source><year>2018</year><volume>3</volume><fpage>1153</fpage><lpage>1160</lpage><pub-id pub-id-type="pmid">30150732</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name><etal/></person-group><article-title>Crystal Structure of Refolding Fusion Core of Lassa Virus GP2 and Design of Lassa Virus Fusion Inhibitors</article-title><source>Front Microbiol</source><year>2019</year><volume>10</volume><elocation-id>1829</elocation-id><pub-id pub-id-type="pmcid">PMC6700223</pub-id><pub-id pub-id-type="pmid">31456769</pub-id><pub-id pub-id-type="doi">10.3389/fmicb.2019.01829</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Igonet</surname><given-names>S</given-names></name><etal/></person-group><article-title>X-ray structure of the arenavirus glycoprotein GP2 in its postfusion hairpin conformation</article-title><source>Proc Natl Acad Sci U S A</source><year>2011</year><volume>108</volume><fpage>19967</fpage><lpage>19972</lpage><pub-id pub-id-type="pmcid">PMC3250147</pub-id><pub-id pub-id-type="pmid">22123988</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1108910108</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Israeli</surname><given-names>H</given-names></name><name><surname>Cohen-Dvashi</surname><given-names>H</given-names></name><name><surname>Shulman</surname><given-names>A</given-names></name><name><surname>Shimon</surname><given-names>A</given-names></name><name><surname>Diskin</surname><given-names>R</given-names></name></person-group><article-title>Mapping of the Lassa virus LAMP1 binding site reveals unique determinants not shared by other old world arenaviruses</article-title><source>PLoS Pathog</source><year>2017</year><volume>13</volume><elocation-id>e1006337</elocation-id><pub-id pub-id-type="pmcid">PMC5423696</pub-id><pub-id pub-id-type="pmid">28448640</pub-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1006337</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowden</surname><given-names>TA</given-names></name><etal/></person-group><article-title>Unusual molecular architecture of the machupo virus attachment glycoprotein</article-title><source>J Virol</source><year>2009</year><volume>83</volume><fpage>8259</fpage><lpage>8265</lpage><pub-id pub-id-type="pmcid">PMC2715760</pub-id><pub-id pub-id-type="pmid">19494008</pub-id><pub-id pub-id-type="doi">10.1128/JVI.00761-09</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parsy</surname><given-names>ML</given-names></name><name><surname>Harlos</surname><given-names>K</given-names></name><name><surname>Huiskonen</surname><given-names>JT</given-names></name><name><surname>Bowden</surname><given-names>TA</given-names></name></person-group><article-title>Crystal structure of Venezuelan hemorrhagic fever virus fusion glycoprotein reveals a class 1 postfusion architecture with extensive glycosylation</article-title><source>J Virol</source><year>2013</year><volume>87</volume><fpage>13070</fpage><lpage>13075</lpage><pub-id pub-id-type="pmcid">PMC3838125</pub-id><pub-id pub-id-type="pmid">24049182</pub-id><pub-id pub-id-type="doi">10.1128/JVI.02298-13</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>WM</given-names></name><etal/></person-group><article-title>Contrasting Modes of New World Arenavirus Neutralization by Immunization-Elicited Monoclonal Antibodies</article-title><source>mBio</source><year>2022</year><elocation-id>e0265021</elocation-id><pub-id pub-id-type="pmcid">PMC9040744</pub-id><pub-id pub-id-type="pmid">35315691</pub-id><pub-id pub-id-type="doi">10.1128/mbio.02650-21</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahmutovic</surname><given-names>S</given-names></name><etal/></person-group><article-title>Molecular Basis for Antibody-Mediated Neutralization of New World Hemorrhagic Fever Mammarenaviruses</article-title><source>Cell Host Microbe</source><year>2015</year><volume>18</volume><fpage>705</fpage><lpage>713</lpage><pub-id pub-id-type="pmcid">PMC4685251</pub-id><pub-id pub-id-type="pmid">26651946</pub-id><pub-id pub-id-type="doi">10.1016/j.chom.2015.11.005</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeltina</surname><given-names>A</given-names></name><etal/></person-group><article-title>Convergent immunological solutions to Argentine hemorrhagic fever virus neutralization</article-title><source>Proc Natl Acad Sci U S A</source><year>2017</year><volume>114</volume><fpage>7031</fpage><lpage>7036</lpage><pub-id pub-id-type="pmcid">PMC5502616</pub-id><pub-id pub-id-type="pmid">28630325</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1702127114</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>LE</given-names></name><etal/></person-group><article-title>Vaccine-elicited receptor-binding site antibodies neutralize two New World hemorrhagic fever arenaviruses</article-title><source>Nat Commun</source><year>2018</year><volume>9</volume><elocation-id>1884</elocation-id><pub-id pub-id-type="pmcid">PMC5951886</pub-id><pub-id pub-id-type="pmid">29760382</pub-id><pub-id pub-id-type="doi">10.1038/s41467-018-04271-z</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abraham</surname><given-names>J</given-names></name><name><surname>Corbett</surname><given-names>KD</given-names></name><name><surname>Farzan</surname><given-names>M</given-names></name><name><surname>Choe</surname><given-names>H</given-names></name><name><surname>Harrison</surname><given-names>SC</given-names></name></person-group><article-title>Structural basis for receptor recognition by New World hemorrhagic fever arenaviruses</article-title><source>Nat Struct Mol Biol</source><year>2010</year><volume>17</volume><fpage>438</fpage><lpage>444</lpage><pub-id pub-id-type="pmcid">PMC2920743</pub-id><pub-id pub-id-type="pmid">20208545</pub-id><pub-id pub-id-type="doi">10.1038/nsmb.1772</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wrapp</surname><given-names>D</given-names></name><etal/></person-group><article-title>Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation</article-title><source>Science</source><year>2020</year><volume>367</volume><fpage>1260</fpage><lpage>1263</lpage><pub-id pub-id-type="pmcid">PMC7164637</pub-id><pub-id pub-id-type="pmid">32075877</pub-id><pub-id pub-id-type="doi">10.1126/science.abb2507</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeltina</surname><given-names>A</given-names></name><etal/></person-group><article-title>Convergent immunological solutions to Argentine hemorrhagic fever virus neutralization</article-title><source>Proc Natl Acad Sci USA</source><year>2017</year><volume>114</volume><fpage>7031</fpage><lpage>7036</lpage></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>WM</given-names></name><name><surname>Stelfox</surname><given-names>AJ</given-names></name><name><surname>Bowden</surname><given-names>TA</given-names></name></person-group><article-title>Unraveling virus relationships by structure-based phylogenetic classification</article-title><source>Virus Evol</source><year>2020</year><volume>6</volume><elocation-id>veaa003</elocation-id><pub-id pub-id-type="pmcid">PMC7015158</pub-id><pub-id pub-id-type="pmid">32064119</pub-id><pub-id pub-id-type="doi">10.1093/ve/veaa003</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Structure of the Lassa virus glycan shield provides a model for immunological resistance</article-title><source>Proc Natl Acad Sci USA</source><year>2018</year><volume>115</volume><fpage>7320</fpage><lpage>7325</lpage><pub-id pub-id-type="pmcid">PMC6048489</pub-id><pub-id pub-id-type="pmid">29941589</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1803990115</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sommerstein</surname><given-names>R</given-names></name><etal/></person-group><article-title>Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection</article-title><source>PLoS Pathog</source><year>2015</year><volume>11</volume><elocation-id>e1005276</elocation-id><pub-id pub-id-type="pmcid">PMC4654586</pub-id><pub-id pub-id-type="pmid">26587982</pub-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1005276</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pettersen</surname><given-names>EF</given-names></name><etal/></person-group><article-title>UCSF ChimeraX: Structure visualization for researchers, educators, and developers</article-title><source>Protein Sci</source><year>2021</year><volume>30</volume><fpage>70</fpage><lpage>82</lpage><pub-id pub-id-type="pmcid">PMC7737788</pub-id><pub-id pub-id-type="pmid">32881101</pub-id><pub-id pub-id-type="doi">10.1002/pro.3943</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bentim Goes</surname><given-names>LG</given-names></name><etal/></person-group><article-title>Highly Diverse Arenaviruses in Neotropical Bats, Brazil</article-title><source>Emerg Infect Dis</source><year>2022</year><volume>28</volume><fpage>2528</fpage><lpage>2533</lpage><pub-id pub-id-type="pmcid">PMC9707603</pub-id><pub-id pub-id-type="pmid">36417964</pub-id><pub-id pub-id-type="doi">10.3201/eid2812.220980</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cajimat</surname><given-names>MN</given-names></name><name><surname>Milazzo</surname><given-names>ML</given-names></name><name><surname>Bradley</surname><given-names>RD</given-names></name><name><surname>Fulhorst</surname><given-names>CF</given-names></name></person-group><article-title>Ocozocoautla de espinosa virus and hemorrhagic fever, Mexico</article-title><source>Emerg Infect Dis</source><year>2012</year><volume>18</volume><fpage>401</fpage><lpage>405</lpage><pub-id pub-id-type="pmcid">PMC3309595</pub-id><pub-id pub-id-type="pmid">22377271</pub-id><pub-id pub-id-type="doi">10.3201/eid1803.111602</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lendino</surname><given-names>A</given-names></name><name><surname>Castellanos</surname><given-names>AA</given-names></name><name><surname>Pigott</surname><given-names>DM</given-names></name><name><surname>Han</surname><given-names>BA</given-names></name></person-group><article-title>A review of emerging health threats from zoonotic New World mammarenaviruses</article-title><source>BMC Microbiol</source><year>2024</year><volume>24</volume><fpage>115</fpage><pub-id pub-id-type="pmcid">PMC10993514</pub-id><pub-id pub-id-type="pmid">38575867</pub-id><pub-id pub-id-type="doi">10.1186/s12866-024-03257-w</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porta</surname><given-names>C</given-names></name><etal/></person-group><article-title>Rational engineering of recombinant picornavirus capsids to produce safe, protective vaccine antigen</article-title><source>PLoS Pathog</source><year>2013</year><volume>9</volume><elocation-id>e1003255</elocation-id><pub-id pub-id-type="pmcid">PMC3609824</pub-id><pub-id pub-id-type="pmid">23544011</pub-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1003255</pub-id></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLellan</surname><given-names>JS</given-names></name><etal/></person-group><article-title>Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus</article-title><source>Science</source><year>2013</year><volume>342</volume><fpage>592</fpage><lpage>598</lpage><pub-id pub-id-type="pmcid">PMC4461862</pub-id><pub-id pub-id-type="pmid">24179220</pub-id><pub-id pub-id-type="doi">10.1126/science.1243283</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsieh</surname><given-names>CL</given-names></name><etal/></person-group><article-title>Structure-based design of prefusion-stabilized human metapneumovirus fusion proteins</article-title><source>Nat Commun</source><year>2022</year><volume>13</volume><elocation-id>1299</elocation-id><pub-id pub-id-type="pmcid">PMC8921277</pub-id><pub-id pub-id-type="pmid">35288548</pub-id><pub-id pub-id-type="doi">10.1038/s41467-022-28931-3</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Branco</surname><given-names>LM</given-names></name><etal/></person-group><article-title>Shedding of soluble glycoprotein 1 detected during acute Lassa virus infection in human subjects</article-title><source>Virol J</source><year>2010</year><volume>7</volume><fpage>306</fpage><pub-id pub-id-type="pmcid">PMC2993672</pub-id><pub-id pub-id-type="pmid">21062490</pub-id><pub-id pub-id-type="doi">10.1186/1743-422X-7-306</pub-id></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berrow</surname><given-names>NS</given-names></name><etal/></person-group><article-title>A versatile ligation-independent cloning method suitable for high-throughput expression screening applications</article-title><source>Nucleic Acids Res</source><year>2007</year><volume>35</volume><fpage>e45</fpage><pub-id pub-id-type="pmcid">PMC1874605</pub-id><pub-id pub-id-type="pmid">17317681</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkm047</pub-id></element-citation></ref><ref id="R58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paesen</surname><given-names>GC</given-names></name><etal/></person-group><article-title>X-ray structure and activities of an essential Mononegavirales L-protein domain</article-title><source>Nat Commun</source><year>2015</year><volume>6</volume><elocation-id>8749</elocation-id><pub-id pub-id-type="pmcid">PMC4659945</pub-id><pub-id pub-id-type="pmid">26549102</pub-id><pub-id pub-id-type="doi">10.1038/ncomms9749</pub-id></element-citation></ref><ref id="R59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>TG</given-names></name><etal/></person-group><article-title>Development of the Twin-Strep-tag(R) and its application for purification of recombinant proteins from cell culture supernatants</article-title><source>Protein Expr Purif</source><year>2013</year><volume>92</volume><fpage>54</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">24012791</pub-id></element-citation></ref><ref id="R60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Chapman</surname><given-names>DA</given-names></name><name><surname>Jones</surname><given-names>IM</given-names></name></person-group><article-title>Improving baculovirus recombination</article-title><source>Nucleic Acids Res</source><year>2003</year><volume>31</volume><elocation-id>E6-6</elocation-id><pub-id pub-id-type="pmcid">PMC140531</pub-id><pub-id pub-id-type="pmid">12527795</pub-id><pub-id pub-id-type="doi">10.1093/nar/gng006</pub-id></element-citation></ref><ref id="R61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strober</surname><given-names>W</given-names></name></person-group><article-title>Trypan Blue Exclusion Test of Cell Viability</article-title><source>Curr Protoc Immunol</source><year>2015</year><volume>111</volume><elocation-id>A3 B 1-A3 B 3</elocation-id><pub-id pub-id-type="pmcid">PMC6716531</pub-id><pub-id pub-id-type="pmid">26529666</pub-id><pub-id pub-id-type="doi">10.1002/0471142735.ima03bs111</pub-id></element-citation></ref><ref id="R62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walter</surname><given-names>TS</given-names></name><etal/></person-group><article-title>A procedure for setting up high-throughput nanolitre crystallization experiments. Crystallization workflow for initial screening, automated storage, imaging and optimization</article-title><source>Acta Crystallogr D Biol Crystallogr</source><year>2005</year><volume>61</volume><fpage>651</fpage><lpage>657</lpage><pub-id pub-id-type="pmcid">PMC7159505</pub-id><pub-id pub-id-type="pmid">15930615</pub-id><pub-id pub-id-type="doi">10.1107/S0907444905007808</pub-id></element-citation></ref><ref id="R63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winter</surname><given-names>G</given-names></name><name><surname>Lobley</surname><given-names>CM</given-names></name><name><surname>Prince</surname><given-names>SM</given-names></name></person-group><article-title>Decision making in xia2</article-title><source>Acta Crystallogr D Biol Crystallogr</source><year>2013</year><volume>69</volume><fpage>1260</fpage><lpage>1273</lpage><pub-id pub-id-type="pmcid">PMC3689529</pub-id><pub-id pub-id-type="pmid">23793152</pub-id><pub-id pub-id-type="doi">10.1107/S0907444913015308</pub-id></element-citation></ref><ref id="R64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCoy</surname><given-names>AJ</given-names></name><etal/></person-group><article-title>Phaser crystallographic software</article-title><source>J Appl Crystallogr</source><year>2007</year><volume>40</volume><fpage>658</fpage><lpage>674</lpage><pub-id pub-id-type="pmcid">PMC2483472</pub-id><pub-id pub-id-type="pmid">19461840</pub-id><pub-id pub-id-type="doi">10.1107/S0021889807021206</pub-id></element-citation></ref><ref id="R65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emsley</surname><given-names>P</given-names></name><name><surname>Lohkamp</surname><given-names>B</given-names></name><name><surname>Scott</surname><given-names>WG</given-names></name><name><surname>Cowtan</surname><given-names>K</given-names></name></person-group><article-title>Features and development of Coot</article-title><source>Acta Crystallogr D Biol Crystallogr</source><year>2010</year><volume>66</volume><fpage>486</fpage><lpage>501</lpage><pub-id pub-id-type="pmcid">PMC2852313</pub-id><pub-id pub-id-type="pmid">20383002</pub-id><pub-id pub-id-type="doi">10.1107/S0907444910007493</pub-id></element-citation></ref><ref id="R66"><label>66</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bricogne</surname><given-names>G</given-names></name><etal/></person-group><source>BUSTER version 2.10.4</source><publisher-loc>Cambridge, United Kingdom</publisher-loc><publisher-name>Global Phasing Ltd</publisher-name><year>2021</year></element-citation></ref><ref id="R67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>PD</given-names></name><etal/></person-group><article-title>PHENIX: a comprehensive Python-based system for macromolecular structure solution</article-title><source>Acta Crystallogr D Biol Crystallogr</source><year>2010</year><volume>66</volume><fpage>213</fpage><lpage>221</lpage><pub-id pub-id-type="pmcid">PMC2815670</pub-id><pub-id pub-id-type="pmid">20124702</pub-id><pub-id pub-id-type="doi">10.1107/S0907444909052925</pub-id></element-citation></ref><ref id="R68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>IW</given-names></name><etal/></person-group><article-title>MolProbity: all-atom contacts and structure validation for proteins and nucleic acids</article-title><source>Nucleic Acids Res</source><year>2007</year><volume>35</volume><fpage>W375</fpage><lpage>383</lpage><pub-id pub-id-type="pmcid">PMC1933162</pub-id><pub-id pub-id-type="pmid">17452350</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkm216</pub-id></element-citation></ref><ref id="R69"><label>69</label><element-citation publication-type="web"><person-group person-group-type="author"><name><surname>Schrödinger</surname><given-names>L</given-names></name><name><surname>DeLano</surname><given-names>W</given-names></name></person-group><source>PyMol</source><year>2020</year><comment><ext-link ext-link-type="uri" xlink:href="http://www.pymol.org/pymol">http://www.pymol.org/pymol</ext-link></comment></element-citation></ref><ref id="R70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heinig</surname><given-names>M</given-names></name><name><surname>Frishman</surname><given-names>D</given-names></name></person-group><article-title>STRIDE: a web server for secondary structure assignment from known atomic coordinates of proteins</article-title><source>Nucleic Acids Res</source><year>2004</year><volume>32</volume><fpage>W500</fpage><lpage>502</lpage><pub-id pub-id-type="pmcid">PMC441567</pub-id><pub-id pub-id-type="pmid">15215436</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkh429</pub-id></element-citation></ref><ref id="R71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abhinandan</surname><given-names>KR</given-names></name><name><surname>Martin</surname><given-names>AC</given-names></name></person-group><article-title>Analysis and improvements to Kabat and structurally correct numbering of antibody variable domains</article-title><source>Mol Immunol</source><year>2008</year><volume>45</volume><fpage>3832</fpage><lpage>3839</lpage><pub-id pub-id-type="pmid">18614234</pub-id></element-citation></ref><ref id="R72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Notredame</surname><given-names>C</given-names></name><name><surname>Higgins</surname><given-names>DG</given-names></name><name><surname>Heringa</surname><given-names>J</given-names></name></person-group><article-title>T-Coffee: A novel method for fast and accurate multiple sequence alignment</article-title><source>J Mol Biol</source><year>2000</year><volume>302</volume><fpage>205</fpage><lpage>217</lpage><pub-id pub-id-type="pmid">10964570</pub-id></element-citation></ref><ref id="R73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robert</surname><given-names>X</given-names></name><name><surname>Gouet</surname><given-names>P</given-names></name></person-group><article-title>Deciphering key features in protein structures with the new ENDscript server</article-title><source>Nucleic Acids Res</source><year>2014</year><volume>42</volume><fpage>W320</fpage><lpage>324</lpage><pub-id pub-id-type="pmcid">PMC4086106</pub-id><pub-id pub-id-type="pmid">24753421</pub-id><pub-id pub-id-type="doi">10.1093/nar/gku316</pub-id></element-citation></ref><ref id="R74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adasme</surname><given-names>MF</given-names></name><etal/></person-group><article-title>PLIP 2021: expanding the scope of the protein-ligand interaction profiler to DNA and RNA</article-title><source>Nucleic Acids Res</source><year>2021</year><volume>49</volume><fpage>W530</fpage><lpage>W534</lpage><pub-id pub-id-type="pmcid">PMC8262720</pub-id><pub-id pub-id-type="pmid">33950214</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkab294</pub-id></element-citation></ref><ref id="R75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bamford</surname><given-names>DH</given-names></name><name><surname>Grimes</surname><given-names>JM</given-names></name><name><surname>Stuart</surname><given-names>DI</given-names></name></person-group><article-title>What does structure tell us about virus evolution?</article-title><source>Curr Opin Struct Biol</source><year>2005</year><volume>15</volume><fpage>655</fpage><lpage>663</lpage><pub-id pub-id-type="pmid">16271469</pub-id></element-citation></ref><ref id="R76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stuart</surname><given-names>DI</given-names></name><name><surname>Levine</surname><given-names>M</given-names></name><name><surname>Muirhead</surname><given-names>H</given-names></name><name><surname>Stammers</surname><given-names>DK</given-names></name></person-group><article-title>Crystal structure of cat muscle pyruvate kinase at a resolution of 2.6 Å</article-title><source>J Mol Biol</source><year>1979</year><volume>134</volume><fpage>109</fpage><lpage>142</lpage><pub-id pub-id-type="pmid">537059</pub-id></element-citation></ref><ref id="R77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stelfox</surname><given-names>AJ</given-names></name><etal/></person-group><article-title>Crystal structure and solution state of the C-terminal head region of the narmovirus receptor binding protein</article-title><source>mBio</source><year>2023</year><volume>14</volume><elocation-id>e0139123</elocation-id><pub-id pub-id-type="pmcid">PMC10653815</pub-id><pub-id pub-id-type="pmid">37737607</pub-id><pub-id pub-id-type="doi">10.1128/mbio.01391-23</pub-id></element-citation></ref><ref id="R78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Felsenstein</surname><given-names>J</given-names></name></person-group><article-title>PHYLIP - Phylogeny Inference Package (Version 3.2)</article-title><source>Cladistics</source><year>1989</year><volume>5</volume><fpage>164</fpage><lpage>166</lpage></element-citation></ref></ref-list></back><floats-group><boxed-text id="BX1" position="float" orientation="portrait"><caption><title>Importance</title></caption><p>Although the emergence of New World (NW) hemorrhagic fever mammarenaviruses poses an unceasing threat to human health, there is a paucity of reagents capable of protecting against the transmission of these pathogens from their natural rodent reservoirs. This is, in part, attributed to our limited understanding of structure and function of the NW glycoprotein spike complex presented on the NW arenavirus surface. Here, we provide a detailed molecular-level description of how the two major components of this key therapeutic target assemble to form a key building block of the NW arenaviral spike complex. The insights gleaned from this work provide a framework for guiding the structure-based development of NW arenaviral vaccines.</p></boxed-text><fig id="F1" position="float"><label>Figure 1</label><caption><title>Structures of JUNV GP1-GP2 (top) and MACV GP1-GP2 (bottom).</title><p>(<bold>A</bold>) Linear representation of the translation product of the JUNV spike gene, showing the SSP in grey, GP1 in violet and GP2 in pale blue. The black triangles indicate the SPase and SKI-1 cleavage sites, the pins represent N-linked glycosylation sites. Pins are colored black if the glycan was observed to be ordered and occupied, grey if not. The strap domain is indicated, as are the fusion peptides (ƒ), the Heptad Repeat regions (HR1 and HR2 (<xref ref-type="bibr" rid="R30">30</xref>)), the T-loop, the membrane-proximal external region (MPER), the transmembrane domain (TM) and the intra-virion (cytosolic) domain (IV). Disulfide bonds are indicated by yellow brackets. (<bold>B</bold>) Linear representation of the JUNV GP1<sup>88-329</sup>GP2<sup>e</sup> construct. The signal peptide and twin-strep tag are not shown. The added disulfide bond is indicated by the yellow bracket, the introduced furin site by the black triangle. A proline (E321P) was also included, as incorporated in the study of LASV GP structure (<xref ref-type="bibr" rid="R13">13</xref>). The TM and IV regions were not included in the constructs. (<bold>C</bold>) Crystal structure of the JUNV GP1-GP2<sup>e</sup> protein in complex with Fab fragments of neutralizing mAb JUN1. JUNV GP1-GP2 is shown in cartoon representation. The GP1 chain is in pink, except for the N-terminal strap (magenta) and the C-terminal α4-helix (red). The GP2 chain is colored blue, except for the T-loop region (cyan). The Fab from JUN1 is shown as ribbons, with the heavy chain in gold and the light chain in turquoise. Glycans are shown as sticks and colored according to the location of their sequon. Disulfide bonds are shown as yellow sticks. The insets show close-ups of the GP1-GP2 interface. The added cysteines forming the inter-chain disulfide bond are labelled. (<bold>D</bold> and <bold>E</bold>) Linear representation of the translation product of the MACV spike gene and of the MACV GP1<sup>88-340</sup>GP2<sup>e</sup> construct, respectively, using the same color scheme and symbols as in panels <italic>A</italic> and <italic>B</italic>, but with E→P denoting an E340P mutation. The mutation of Glu258 into a serine N-terminal of the furin-site in the MACV construct introduced an extra NXS glycosylation sequon (pink pin) to the ‘SKI-loop’. This loop is not seen in the crystal structure, so any bound glycans are not visible. (<bold>F</bold>) Crystal structure of the MACV GP1-GP2<sup>e</sup> protein (cartoon) in complex with Fab fragments of neutralizing mAb MAC1 (ribbon). Colors and labelling are as in panel <italic>C</italic>.</p></caption><graphic xlink:href="EMS199188-f001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><title>Structure-based classification of NW and OW arenaviral GP1 glycoproteins.</title><p>Structure-based classification illustrates the similarity of NW GP1 glycoproteins in GP2 attached and detached states. A pairwise distance matrix was calculated with Structural Homology Program (SHP) (<xref ref-type="bibr" rid="R75">75</xref>, <xref ref-type="bibr" rid="R76">76</xref>). Pairwise evolutionary distance matrices were used to generate un-rooted phylogenetic trees in PHYLIP (<xref ref-type="bibr" rid="R78">78</xref>). JUNV GP1, in the GP2 attached state, is shown in cartoon representation and colored as a rainbow from the N-terminus (blue) to C-terminus (red). Cartoon tube coloring from blue to orange, with increasing tube thickness, reflects increased structural distance from JUNV GP1 in the GP2-attached state upon overlay. Non-equivalent residues are colored red with exaggerated thickness.</p></caption><graphic xlink:href="EMS199188-f002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><title>The N-terminal GP1 strap.</title><p>(<bold>A</bold>) Overview of interactions between the GP1 strap and GP2. Given that the straps of JUNV and MACV are similar, the strap of JUNV was chosen for comparison with LASV. The GP1 strap is shown as a magenta cartoon, with side chains shown as sticks. GP2 is shown in surface representation, with basic and acidic patches colored blue and red, respectively. Residues occupying the long groove on the GP2 surface are labelled with bold letter types for Phe75 (in black), Phe70 (purple), Phe62 (orange), and Ile64 (blue). Labels for the helices and strands at the GP1-GP2 interface are highlighted in green. (<bold>B</bold>) Binding of Phe75 of the strap to a conserved, hydrophobic pocket in GP2. Strap residues are shown in magenta, GP2 residues in light blue or, if they belong to the T-loop, in cyan. Hydrogen bonds are shown as orange lines, hydrophobic bonds as violet dashed lines. GP2 residues forming the pocket are conserved in NW and OW viruses, but Phe75 of the strap is frequently replaced by a leucine, isoleucine, or valine (see <bold>Supplementary Fig. S6</bold>). (<bold>C</bold>) Comparison of the interactions at the N-terminal tip of the strap between the JUNV (<italic>a, b</italic>) and LASV (<italic>c, d</italic>) structures. In JUNV, Phe70 occupies a rather shallow, hydrophobic pocket, which consists of mostly aromatic GP2 residues (<italic>a</italic>). GP1 residues Phe62 and Ile64 join the pocket. Trp395 (labelled in red) plays a central role in the interaction, forming connections with Phe70 and Ile64, and π–stacking interactions with Phe62 (indicated by the green dashed lines and spheres denoting the aromatic ring centers). Trp395 and Ile388 link the C-terminal helix of the ectodomain (α9; <italic>b</italic>) to the N-terminal β-strands of the strap (β1, β2; the N-terminus is denoted by ‘<italic>N</italic>’). Interactions in LASV (PDB 7PUY) at the level of Ile68 (equivalent to Phe70 of JUNV) are markedly different (<italic>c</italic>, <italic>d</italic>, and <bold>Supplementary Fig. S6</bold>). Ile403 (in red), which is strictly conserved in OW-viruses, takes the place of the much larger Trp395 (fully conserved in NW-viruses) on the C-terminal helix (α11, <italic>d</italic>). The smaller Ile403 partners with the aromatic Tyr62, which is also conserved in OW-viruses and replaces Ile64, the smaller, NW-specific partner of Trp395. Phe62 of JUNV, another residue that interacts with Trp395 and which is also conserved as a hydrophobic residue in NW-viruses, is replaced by Ser60 in LASV, which is not conserved in OW-viruses and does not contribute to the strap-GP2 interaction, as observed in PDB ID 7PUY (shown as lines). Similarly, Trp386 (Trp378 in JUNV), Phe399 (Phe391) and Leu372 (Val364) do not bind the N-terminus of the strap in LASV.</p></caption><graphic xlink:href="EMS199188-f003"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><title>Interactions at the C-terminal region of the strap.</title><p><bold>(A)</bold> Interactions between the C-terminal part of the strap domain in JUNV and the α6 helix of GP2, which in turn interacts with the structurally ordered portion of the N-terminal fusion peptide segment (N-FPS). The strap domain is colored magenta, GP2 domains are colored blue. The side chains of selected residues and main chain atoms that form inter-chain hydrogen bonds are shown as sticks. Strap residues are labelled in bold. Hydrogen bonds are shown as solid orange lines, hydrophobic interactions as violet dotted lines, and π–stacking interactions as green dashed lines with spheres denoting the aromatic ring centers. (<bold>B</bold>) Direct interactions between the C-terminal part of the strap in JUNV and the internal fusion peptide segment (i-FPS). (<bold>C</bold>) Interactions between the C-terminal part of the strap and the i-FPS in MACV. The purple arrow indicates the orientation of α-helix 1, which contrasts that observed in JUNV GP1. Instead of Asn83 interacting with i-FPS, as observed in JUNV GP1-GP2, Asn83 in MACV GP1-GP2 is distal from the fusion peptide and glycosylated. N-linked glycosylation is also found at the corresponding position in the GP1s of LASV (Asn79) and LCMV (Asn85), at a conserved NXS/T sequon at the C-terminus of η1 (<bold>Supplementary Fig. S6</bold>) and is similarly directed away from the fusion peptide.</p></caption><graphic xlink:href="EMS199188-f004"/></fig><fig id="F5" position="float"><label>Figure 5</label><caption><title>α-helix 4 of the GP1 is centrally located in the GP1-GP2 interface.</title><p><bold>(A)</bold> Overview, in cartoon representation, of the interaction between the α-helix 4 (colored red) of the JUNV GP1 (colored pink, except for a4) and JUNV GP2 (colored blue, except for the T-loop; cyan). The a4-helix is centrally positioned at the GP1-GP2 interface and embedded within the JUNV GP1 core structure, in part, through hydrophobic interactions with Phe236. <bold>(B)</bold> Close-up of the interface between α-helix 4 and GP2, which includes interactions between T-loop residue Tyr358 and α-helices 7 and 8. Hydrogen bonds are shown as orange lines, hydrophobic interactions as violet, dotted lines, and potential bonds via waters as white lines. (<bold>C</bold>) Interactions between α4 and the rest of the GP1 subunit. Phe236 forms part of a hydrophobic cluster comprised of Ala151, Trp144, Pro89, Ile101, Le91 and Leu199. Yellow dotted lines represent salt bridges. Interactions with α1 of the N-terminal strap are also shown. (<bold>D</bold>) Interactions between α3 of JUNV GP1 with GP2. Arg201 of GP1 forms interactions with residues adjacent to the disulfide bridge bordering the T-loop region (Cys356-Cys377; yellow sticks).</p></caption><graphic xlink:href="EMS199188-f005"/></fig><fig id="F6" position="float"><label>Figure 6</label><caption><title>Comparison of GP1-GP2 heterodimers and higher-order trimeric assemblies.</title><p>(<bold>A</bold>) The JUNV GP1<sup>88-329</sup>GP2<sup>e</sup> structure, with GP1 (pink) and GP2 (blue), superposed onto LASV (7PUY) GP1-GP2 (yellow). The labels for the structural elements are colored red for the JUNV structure and black for the LASV structure. The symbols α, β and η indicate α-helices, β-strands and 3<sub>10</sub>-helices, respectively. The highly conserved GP2 subunits align well, apart from the helices at the C-terminus of the ectodomains (α9 in JUNV, α10 in LASV), which bend in different directions, likely due to the presence of the transmembrane region (TM) in the LASV structure. In JUNV and MACV, the loop that connects α-helix 1 of the GP2 embedded strap domain to β-strand 3 at the ‘bottom’ of the β-sheet in GP1 is longer than that in LASV. Loop and β3-strand are shown in red in JUNV and gold in LASV. The longer loop allows the entire β-sheet to move ‘upwards’, <italic>i.e</italic>. further away from GP2 than in LASV. (<bold>B</bold>) To model the trimeric JUNV spike, three copies of the JUNV GP1<sup>88-329</sup>GP2<sup>e</sup> heterodimer were superposed onto a trimeric LASV GP structure (PDB ID 7PUY; (<xref ref-type="bibr" rid="R14">14</xref>)). The copies fit well into the modelled spike without major clashes, however, some flexibility may be required at the α2-β7 loop, which may otherwise be too close to 3<sub>10</sub>-helix 1 of a neighboring GP1 subunit. The model is shown in cartoon- (left) and surface-representation (middle), with the heterodimers shown in grey, green and orange, using lighter shades for the GP1 subunits. Glycans are shown as yellow sticks. The LASV structure (right) is shown for comparison, using the same color scheme, with the transparent surface showing the TM region. The model suggests the JUNV spike is more elongated than LASV, due in part to the upward shift of the GP1-sheet.</p></caption><graphic xlink:href="EMS199188-f006"/></fig><fig id="F7" position="float"><label>Figure 7</label><caption><title>Mapping the putative trajectory of the SKI-loop.</title><p>(<bold>A</bold>) The surfaces of LASV (PDB 7PUY), JUNV, and MACV GP1-GP2 heterodimers, colored from red (negative surface charge) to blue (positive), as seen from the interior of the trimer. The LASV GP1 surface presents a well-defined groove that can accommodate the C-terminal SKI-loop (<italic>i.e.</italic> the loop containing the SKI-1 recognition site following cleavage) protruding from a neighboring GP1 (yellow sticks) (<xref ref-type="bibr" rid="R14">14</xref>). In contrast, JUNV and MACV present a more negatively charged surface. Assuming LASV-like binding of the SKI-loop occurs in JUNV and MACV, the N-terminal end of the loop may be impeded by the side chains of Trp143 and Trp147, whilst the cleavage-site peptide could be sandwiched by the side chains of His128 and His157 (JUNV), or Glu128 and Leu157 (MACV). The yellow, dashed line indicates such putative trajectory in JUNV. (<bold>B</bold>) (left) Binding of the SKI-loop of protomer C (cartoon representation, blue) by protomer A (with GP1 in yellow, GP2 in gold), as it occurs in LASV GP (<xref ref-type="bibr" rid="R14">14</xref>). For clarity, the SKI-loops were deleted from protomers A and B. (right) Comparison with a trimeric JUNV GP model. The trajectory of the SKI-loop, as seen in LASV, is curtailed by the converging His128 and His157 side groups. However, the shift ‘upwards’ of GP1 (<xref ref-type="fig" rid="F6">Fig. 6</xref>) and the change in orientation of α-helix 2, compared to LASV, may create space at the interface with GP2, between the protomers. This suggests alternative routes for the SKI-loops, as indicated by the arrows highlighted in yellow.</p></caption><graphic xlink:href="EMS199188-f007"/></fig></floats-group></article>